PTHS Pelthos Therapeutics Inc.

AMEX
$22.65

Pelthos Therapeutics Inc. (PTHS) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
5
17 transactions
Purchases
$1000.0K
35,948 shares
Sales
$161.1K
6,655 shares
Net activity
$838.9K
purchases less sales

How much of that selling was preplanned? 75% planned / 25% discretionary

10b5-1 plan sales $120.8K 16 transactions · 5,155 shares
Discretionary sales $40.3K 1 transaction · 1,500 shares

Largest single sale: $40.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: June 11, 2026 , by Davis Todd C .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Greenleaf Peter 2 fills Director Sell 10b5-1 797 $26.13 $20.8K 23,969 −3.2% of holding
Pauls Matthew 2 fills Director Sell 10b5-1 786 $26.16 $20.6K 14,458 −5.2% of holding
Friedberg Ezra M 2 fills Director Sell 10b5-1 558 $26.09 $14.6K 81,066 −0.7% of holding
Friedberg Ezra M 2 fills Director Sell 10b5-1 283 $27.29 $7.7K 81,659 −0.3% of holding
Davis Todd C 2 fills Director Buy 35,948 $27.82 $1000.0K 75,834
Francis Knuettel II CFO, Treas & Secty Sell 1,500 $26.84 $40.3K 11,316 −11.7% of holding
Greenleaf Peter 2 fills Director Sell 10b5-1 797 $20.92 $16.7K 25,058 −3.1% of holding
Pauls Matthew 2 fills Director Sell 10b5-1 786 $20.92 $16.4K 15,521 −4.8% of holding
Malamut Richard 2 fills Director Sell 10b5-1 590 $20.92 $12.3K 27,702 −2.1% of holding
Friedberg Ezra M 2 fills Director Sell 10b5-1 558 $20.92 $11.7K 82,292 −0.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.